In this second part of a two-part interview, Dr. Hiren Shah, an assistant professor of medicine at the Feinberg School of Medicine at Northwestern University, talks to DocWire News about new guideline-recommended therapies for treating venous thromboembolism (VTE), as well as how COVID-19 has impacted the treatment of his patients. Dr. Shah also provides a take-away message for VTE specialists. To watch part 1 of this interview, click here.